MISC

国際誌
2008年1月

Effects of deferoxamine-activated hypoxia-inducible factor-1 on the brainstem after subarachnoid hemorrhage in rats

NEUROSURGERY
  • Tomohito Hishikawa
  • ,
  • Shigeki Ono
  • ,
  • Tomoyuki Ogawa
  • ,
  • Koji Tokunaga
  • ,
  • Kenji Sugiu
  • ,
  • Isao Date

62
1
開始ページ
232
終了ページ
240
記述言語
英語
掲載種別
DOI
10.1227/01.NEU.0000296989.61911.81
出版者・発行元
LIPPINCOTT WILLIAMS & WILKINS

OBJECTIVE: Hypoxia-inducible factor (HIF)-1 is a transcription factor that regulates the expression of various neuroprotective genes. The goal of this study was to clarify the relationship between HIF-1 expression and subarachnoid hemorrhage (SAH) and to characterize the effects of deferoxamine (DFO)-induced increases in HIF-1 protein levels on the brainstem and the basilar artery (BA) after experimental SAH.
METHODS: Rat single- and double-hemorrhage models (injected on Days 0 and 2) of SAH were used. We assessed the time courses for HIF-1 protein levels in the brainstems and the BA diameters within 10 minutes and 6 hours on Days 1 and 2 in the single-SAH model, and also on Day 7 in the double-SAH model. After induction of double hemorrhage in rats, DFO was injected intraperitoneally. We then evaluated HIF-1 protein expression and brainstem activity, BA diameter, and brainstem blood flow.
RESULTS: After the rats experienced SAH, HIF-1 protein expression was significantly greater at 10 minutes in the single-injection model and at 7 days in the double-injection model than at similar time points in the control group, and these increases correlated with degrees of cerebral vasospasm. DFO injection resulted in significant increases in HIF-1 protein expression and activity in the brainstems of rats with SAH, compared with the rats with SAH that were given placebos, and the rats without SAH in the double-hemorrhage model. Cerebral vasospasm and reduction of brainstem blood flow were significantly attenuated in the rats that were administered DFO.
CONCLUSION: These results show that a DFO-induced increase in HIF-1 protein level and activity exerts significant attenuation of BA vasospasm and reduction of brainstem blood flow in the rat model of SAH. DFO may be a promising agent for treating clinical SAH.

リンク情報
DOI
https://doi.org/10.1227/01.NEU.0000296989.61911.81
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/18300912
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000252978100048&DestApp=WOS_CPL
ID情報
  • DOI : 10.1227/01.NEU.0000296989.61911.81
  • ISSN : 0148-396X
  • PubMed ID : 18300912
  • Web of Science ID : WOS:000252978100048

エクスポート
BibTeX RIS